Compound Summary
Compound Information
carisoprodol
Compound Name: | carisoprodol |
Compound CID: | 2576 |
Synonyms: | carisoprodol 78-44-4 Isomeprobamate Carisoprodate Carisoprodatum More... |
Iupac Name: | [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate |
InChI: | InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) |
InChIKey: | OFZCIYFFPZCNJE-UHFFFAOYSA-N |
Canonical Smiles: | CCCC(C)(COC(=O)N)COC(=O)NC(C)C |
Isomeric Smiles: | CCCC(C)(COC(=O)N)COC(=O)NC(C)C |
Molecular Weight: | 260.33 |
Molecular Formula: | C12H24N2O4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
carisoprodol
Molecular Weight: | 260.33 |
Molecular Formula: | C12H24N2O4 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 9 |
Heavy Atom Count: | 18 |
Complexity: | 281 |
Synonyms
carisoprodol
| carisoprodol | carisoprodol |
|---|---|
carisoprodol |
78-44-4 |
Isomeprobamate |
Carisoprodate |
Carisoprodatum |
Carisoma |
Isobamate |
Isoprotane |
Isoprothane |
SOMA |
Sanoma |
Isopropyl meprobamate |
Atonalyt |
Flexartal |
Miolisodal |
Mioratrina |
Skutamil |
Somalgit |
Apesan |
Arusal |
Flexal |
Mioril |
Nospasm |
Relasom |
Somanil |
Carlsoprol |
Brianil |
Calenfa |
Caprodat |
Carisol |
Carlsodol |
Carlsoma |
Carsodal |
Diolene |
Domarax |
Isoprotan |
Izoprotan |
Mediquil |
Mioriodol |
Somadril |
Stialgin |
Carisoprodolum |
Carsodol |
RELA |
Carisoprodolum INN-Latin |
Tonolyt isopropyl meprobamate |
NCI-C56235 |
SCH 7307 |
Miolisodol |
Flexartel |
CB 8019 |
2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate |
2-(carbamoyloxymethyl)-2-methylpentyl N-propan-2-ylcarbamate |
(1-Methylethyl)carbamic acid 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester |
Isopropylcarbamic acid, ester with 2-(hydroxymethyl)-2-methylpentyl carbamate |
MLS000028401 |
CHEBI:3419 |
Artifar |
Caridolin |
Chinchen |
Fibrosona |
Flexagilt |
Flexagit |
Flexidon |
Listaflex |
Meprodat |
Neotica |
Muslax |
Scutamil-C |
Carbamic acid, ester with 2-methyl-2-propyl-1,3-propanediol isopropylcarbamate |
MFCD00057661 |
Carbamic acid, (1-methylethyl)-, 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester |
Carbamic acid, (1-methylethyl)-, 2-(aminocarbonyl)oxymethyl-2-methylpentyl ester |
Carbamic acid, isopropyl-, 2-(hydroxymethyl)-2-methylpentyl ester carbamate (ester) |
NSC-172124 |
NCGC00015278-09 |
SMR000058433 |
(+-)-2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate |
DSSTox_CID_4733 |
DSSTox_RID_77514 |
DSSTox_GSID_24733 |
Isopropylmeprobamate |
2-((Carbamoyloxy)methyl)-2-methylpentyl isopropylcarbamate |
2-methyl-2-propyltrimethylene carbamate isopropylcarbamate |
Carisoprodolo DCIT |
N-isopropy-2-methyl-2-propyl-1,3-propanediol dicarbamate |
Carisoprodolo |
Prazolamine |
Carbamic acid 2-isopropylcarbamoyloxymethyl-2-methyl-pentyl ester |
Carbamic acid, ester with 2-(hydroxymethyl)-2-methylpentylisopropyl carbamate |
CCRIS 4764 |
HSDB 3021 |
SR-01000000076 |
EINECS 201-118-7 |
NSC 172124 |
BRN 1791537 |
Carisoprodol USP:INN:BAN |
2-{(aminocarbonyl)oxymethyl}-2-methylpentyl isopropylcarbamate |
Carisoprodol civ |
CAS-78-44-4 |
Prestwick_50 |
Soma (TN) |
N-Isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate |
Spectrum_000102 |
Opera_ID_1100 |
Prestwick0_000423 |
Prestwick1_000423 |
Prestwick2_000423 |
Prestwick3_000423 |
Spectrum2_001153 |
Spectrum3_000328 |
Spectrum4_000265 |
Spectrum5_000661 |
1,3-Propanediol, 2-methyl-2-propyl-, carbamate isopropylcarbamate (ester) |
Carbamic acid, ester with 2-(hydroxymethyl)-2-methylpentyl isopropylcarbamate |
CHEMBL1233 |
Lopac0_000319 |
SCHEMBL33286 |
BSPBio_000406 |
BSPBio_001935 |
KBioGR_000730 |
KBioSS_000542 |
MLS001148409 |
MLS002454391 |
DivK1c_000816 |
SPECTRUM1500162 |
Carisoprodol (JAN/USP/INN) |
SPBio_001105 |
SPBio_002345 |
BPBio1_000448 |
GTPL7610 |
DEA No. 8192 |
DTXSID8024733 |
HMS502I18 |
KBio1_000816 |
KBio2_000542 |
KBio2_003110 |
KBio2_005678 |
KBio3_001155 |
NINDS_000816 |
HMS1569E08 |
HMS1920K03 |
HMS2091A06 |
HMS2096E08 |
HMS2234F13 |
HMS3259O15 |
HMS3372H19 |
HMS3713E08 |
Pharmakon1600-01500162 |
HY-B1380 |
Carisoprodol 1.0 mg/ml in Methanol |
Tox21_110122 |
Tox21_200623 |
AC-212 |
CCG-40092 |
NSC172124 |
NSC756671 |
AKOS015842914 |
Tox21_110122_1 |
WLN: ZVO1X3&1&1OVMY1&1 |
CS-4819 |
DB00395 |
LP00319 |
MCULE-3695657564 |
NC00502 |
NSC-756671 |
SDCCGSBI-0050307.P005 |
IDI1_000816 |
NCGC00015278-03 |
NCGC00015278-04 |
NCGC00015278-05 |
NCGC00015278-06 |
NCGC00015278-07 |
NCGC00015278-08 |
NCGC00015278-11 |
NCGC00015278-12 |
NCGC00015278-14 |
NCGC00015278-15 |
NCGC00089734-02 |
NCGC00089734-03 |
NCGC00089734-04 |
NCGC00089734-05 |
NCGC00089734-06 |
NCGC00089734-07 |
NCGC00258177-01 |
SBI-0050307.P004 |
AB0073030 |
AB00051932 |
EU-0100319 |
FT-0601536 |
FT-0656125 |
ST51037205 |
Carbamic acid,3-propanediol isopropylcarbamate |
C 8759 |
D00768 |
N-Isopropyl-2-methyl-2-propyl-1, dicarbamate |
AB00051932_15 |
057C661 |
Q416905 |
SR-01000000076-2 |
SR-01000000076-4 |
SR-01000000076-6 |
W-104280 |
1, 2-methyl-2-propyl-, carbamate isopropylcarbamate |
Z1565440360 |
N-Isopropyl-2-methyl-2-propyl-1,3-propanediol, dicarbamate |
2-(carbamoyloxy)methyl-2-methylpentyl propan-2-ylcarbamate |
Carisoprodol, European Pharmacopoeia (EP) Reference Standard |
1,3-Propanediol, 2-methyl-2-propyl-, carbamate isopropylcarbamate |
2-(carbamoyloxy)methyl-2-methylpentyl N-(propan-2-yl)carbamate |
2-methyl-2-{N-(methylethyl)carbamoyloxymethyl}pentyl aminooate |
Carisoprodol, United States Pharmacopeia (USP) Reference Standard |
(+/-)-2-methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate |
(RS)-2-{(aminocarbonyl)oxymethyl}-2-methylpentyl isopropylcarbamate |
Carbamic acid, isopropyl-, 2-(hydroxymethyl)-2-methylpentyl ester carbamate |
Carbamic acid, isopropyl-, 2-(hydroxymethyl)-2-methylpentyl ester, carbamate |
Carisoprodol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
Experimental Data
carisoprodol
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 11 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
carisoprodol
Statistics Data
carisoprodol
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 11 | 1 | 1 |
Statistics Data Visualization
carisoprodol
